Trial Profile
A clinical study of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2018
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 29 Jul 2018 New trial record
- 01 Jun 2018 Results assessing anticoagulation efficacy of dabigatran etexilate were published in the Medicine.